Deciphera Pharmaceuticals, Inc.
USD25.59
+0.02 (+0.08%)
CEO
Steven L. Hoerter
IPO Date
2017-09-28
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
Country
US
Open
$25.56
Prev. Close
$25.57
Day Low
$25.56
Day High
$25.61
52W Low
$9.90
52W High
$25.61
Market Cap
$2.21B
Volume
1.57M
| 48,136 |
| $0.01 |
| 20 Feb 2024 | Dhanak Dashyant | EVP & Chief Scientific Officer | A-Award | Acquired | 17,275 | $0.00 |
| 20 Feb 2024 | Dhanak Dashyant | EVP & Chief Scientific Officer | A-Award | Acquired | 69,100 | $15.92 |
| 20 Feb 2024 | Hoerter Steven L. | director, officer: President and CEO | A-Award | Acquired | 298,100 | $15.92 |
| 20 Feb 2024 | Sherman Matthew L | EVP & Chief Medical Officer | A-Award | Acquired | 17,275 | $0.00 |
| 20 Feb 2024 | Sherman Matthew L | EVP & Chief Medical Officer | S-Sale | Disposed | 2,615 | $15.62 |
| 20 Feb 2024 | Sherman Matthew L | EVP & Chief Medical Officer | A-Award | Acquired | 69,100 | $15.92 |
| 20 Feb 2024 | Martin Daniel C. | Chief Commercial Officer | A-Award | Acquired | 9,725 | $0.00 |
| 20 Feb 2024 | Martin Daniel C. | Chief Commercial Officer | S-Sale | Disposed | 2,267 | $15.62 |